Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Nanoviricides - The Other Board -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (797)

6/11/2018 11:12:25 AM

From: Its_lose_not_loose

Respond to of 1010

Thanks for reminding me of the moronic predictions for Monday news. In case you haven't heard, NNVC no longer has Seymour holding the reigns on the fluff PRs. Mind you, Diwan's PRs are all fluff, just not as frequent as Seymour's.

To: donpat who wrote (10456)	6/11/2018 11:08:02 AM
From: donpat	of 10460

Monday, Monday. One of these Mondays!

To: donpat who wrote (797)

6/25/2018 4:28:39 PM

From: Its_lose_not_loose

Respond to of 1010

Thank the Almighty, donpat. There may yet be a cure for what ails you. And I do mean you specifically.

From: donpat	of 10593

Herpes virus linked to Alzheimer's disease in new research 25/06/2018 Newshub staff The results found that two strains of herpes virus were far more plentiful in the brains of those with early-stage Alzheimer's than in healthy controls. Photo credit: File New research shows carrying the herpes virus may contribute to your risk of developing Alzheimer's disease. A study published in the US medical journal Neuron on Thursday reviewed the brains of 622 people showing early signs of Alzheimer's. The results found that two strains of herpes virus were far more plentiful in the brains of those with early-stage Alzheimer's than in healthy controls, the The Guardian reports. The strain of herpes virus most commonly found were the (HHV) 6A and HHV 7. But don't panic. Unlike their better-known cousins HSV 1 and HSV 2, they aren't sexually transmitted. Both viruses affect nerve cells and are more frequently found in patients with neuro-inflammatory diseases such as multiple sclerosis. Scientists are divided on whether viruses are an active trigger, or whether the brains of people already on the path towards the neurodegenerative disease are more vulnerable to infection. "The viral genomes were detectable in about 30 percent of Alzheimer's brains and virtually undetectable in the control group," Sam Gandy, a New York professor of neurology and a co-author of the study, told The Guardian. It's projected that more than 170,000 Kiwis will be living with dementia by 2050. The total cost of dementia to New Zealand is now around $1.7 billion and will reach around $5 billion by 2050. newshub.co.nz cell.com

To: donpat who wrote (797)	6/26/2018 1:18:18 PM
From: arvitar	Respond to of 1010

The FDA - are they directing nnvc's activities? How can anyone who has been pumping this POS day and night for the past 13 years, be so completely ignorant and clueless about what the FDA does? To answer to your question: NO. The FDA is a government regulatory agency. They don't "direct" anything outside of their own office. They review materials sent to them for various types of approval. It's up to each company to follow the federal laws and guidelines on their own. The FDA simply doesn't grant approval otherwise. The first time a company has to depend on the FDA for anything, is when they send them an IND application to review for approval.. NNVC is years away from taking that first step, if we are to believe what they said in their most recent SEC filing.